Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Accessed 13 Jun 2023 Sato N et al (2017) Evaluating the efficacy, safety, and tolerability of serelaxin when added to standard therapy in Asian patients with acute heart failure: design and rationale of RELAX-AHF-ASIA trial
Effects of Prolonged L-carnitine Administration on Delayed Muscle Pain and CK Release After Eccentric Effort 9-Heimo Mairburl*2013 Nov 12
The clinical drug development program was halted in 2007 after the pivotal Phase IIb trial did not show statistically significant weight loss in the primary endpoint
Mounjaro (tirzepatide) EPAR
Design and baseline characteristics of the STRIDE trial: evaluating semaglutide in people with symptomatic peripheral artery disease and type 2 diabetes
US$ 22.05
US$ 25.44
US$ 25.67
US$ 26.64
US$ 20.92
